Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Public Procurement - A ₹88,000 Cr Opportunity for India’s Startups
- Monthly Sector Update | Indian Real Estate | May 2021
- Revenue and Customer Journey Enhancement for a leading full-service brokerage form with 4,00,000+ active retail traders.
- Australia-India interim free trade pact: Everything you need to know
